US Stock MarketDetailed Quotes

PCRX Pacira BioSciences

Watchlist
  • 16.630
  • -0.060-0.36%
Close Oct 16 16:00 ET
  • 16.630
  • 0.0000.00%
Post 16:00 ET
767.09MMarket Cap12.41P/E (TTM)

Pacira BioSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
5.05%178.02M
4.23%167.12M
1.22%674.98M
5.40%181.24M
-2.11%163.93M
0.03%169.47M
1.49%160.34M
23.14%666.82M
8.02%171.96M
31.12%167.47M
Operating revenue
5.05%178.02M
4.23%167.12M
1.22%674.98M
5.40%181.24M
-2.11%163.93M
0.03%169.47M
1.49%160.34M
23.14%666.82M
8.02%171.96M
31.12%167.47M
Cost of revenue
-8.18%44.26M
-3.27%47.42M
-7.34%184.67M
-22.97%47.69M
-21.56%39.75M
-4.78%48.21M
35.89%49.02M
42.09%199.3M
58.73%61.92M
46.25%50.68M
Gross profit
10.31%133.76M
7.53%119.7M
4.87%490.31M
21.37%133.55M
6.33%124.18M
2.08%121.26M
-8.69%111.32M
16.51%467.53M
-8.44%110.04M
25.48%116.79M
Operating expense
4.89%102.79M
2.23%104.59M
1.61%402.99M
3.96%99.59M
8.51%103.1M
-7.21%98M
2.11%102.31M
47.74%396.6M
27.18%95.8M
54.74%95.01M
Selling and administrative expenses
5.05%68.13M
1.67%72.03M
5.86%269.44M
2.86%65.8M
10.87%67.95M
-0.24%64.85M
10.24%70.84M
27.68%254.52M
22.66%63.97M
28.06%61.28M
-Selling and marketing expense
4.23%39.05M
-5.16%39.44M
5.55%153.04M
-0.72%35.74M
13.51%38.26M
1.65%37.46M
8.17%41.58M
--145M
--36M
28.16%33.71M
-General and administrative expense
6.17%29.08M
11.37%32.59M
6.28%116.4M
7.47%30.06M
7.65%29.69M
-2.70%27.39M
13.34%29.26M
--109.52M
--27.97M
27.93%27.58M
Research and development costs
8.04%20.34M
6.41%18.24M
-10.07%76.26M
11.19%19.46M
7.34%20.83M
-28.38%18.82M
-20.67%17.14M
52.66%84.8M
12.83%17.51M
67.60%19.41M
Depreciation amortization depletion
0.00%14.32M
0.00%14.32M
0.00%57.29M
0.00%14.32M
0.00%14.32M
0.00%14.32M
0.00%14.32M
322.70%57.29M
87.14%14.32M
628.11%14.32M
-Depreciation and amortization
0.00%14.32M
0.00%14.32M
0.00%57.29M
0.00%14.32M
0.00%14.32M
0.00%14.32M
0.00%14.32M
322.70%57.29M
87.14%14.32M
628.11%14.32M
Operating profit
33.15%30.98M
67.65%15.12M
23.12%87.32M
138.49%33.97M
-3.22%21.08M
76.55%23.26M
-58.51%9.02M
-46.61%70.93M
-68.26%14.24M
-31.23%21.78M
Net non-operating interest income expense
149.32%865K
109.11%587K
74.99%-8.86M
100.45%37K
91.90%-698K
79.56%-1.75M
35.37%-6.45M
-14.84%-35.43M
20.18%-8.26M
-20.49%-8.62M
Non-operating interest income
124.96%4.75M
24.22%3.9M
151.96%11.44M
22.98%3.43M
124.15%2.77M
737.70%2.11M
1,059.41%3.14M
406.92%4.54M
3,381.25%2.79M
597.18%1.23M
Non-operating interest expense
-1.67%3.12M
-69.54%2.64M
-51.34%17.31M
-71.83%2.7M
-68.94%2.78M
-60.12%3.17M
-4.58%8.65M
22.69%35.58M
-0.50%9.6M
34.29%8.95M
Total other finance cost
10.42%763K
-27.32%681K
-31.91%3M
-52.56%685K
-24.36%683K
-20.94%691K
-20.53%937K
59.77%4.4M
85.60%1.44M
35.59%903K
Other net income (expense)
-70.97%4.74M
92.90%-2.06M
24.47%-16.76M
98.82%-283K
65.92%-3.78M
-6.13%16.34M
-551.04%-29.04M
51.31%-22.19M
40.93%-24.05M
-3,817.67%-11.09M
Special income (charges)
-71.21%4.78M
93.45%-1.9M
-52.01%-16.57M
96.69%-798K
-586.30%-3.36M
-8.00%16.61M
-569.43%-29.03M
74.59%-10.9M
40.63%-24.14M
-106.33%-489K
-Less：Restructuring and merger&acquisition
116.46%2.74M
-84.28%1.9M
-103.23%-352K
-96.69%798K
586.30%3.36M
8.00%-16.61M
179.16%12.11M
-74.59%10.9M
-40.63%24.14M
106.33%489K
-Less:Other special charges
---7.52M
----
--16.93M
--0
----
----
--16.93M
----
----
----
Other non- operating income (expenses)
85.50%-39K
-1,490.00%-159K
98.35%-186K
535.80%515K
96.02%-422K
58.42%-269K
91.94%-10K
-323.41%-11.29M
222.73%81K
-22,939.13%-10.6M
Income before tax
-3.35%36.58M
151.52%13.64M
363.85%61.7M
286.63%33.72M
702.37%16.6M
72.01%37.85M
-462.96%-26.47M
-76.42%13.3M
-191.51%-18.07M
-91.46%2.07M
Income tax
46.37%17.7M
167.18%4.66M
857.42%19.75M
211.10%8.85M
107.93%5.74M
467.39%12.09M
-1,588.84%-6.94M
-118.07%-2.61M
-645.88%-7.97M
-57.97%2.76M
Net income
-26.69%18.89M
145.96%8.98M
163.72%41.96M
346.19%24.87M
1,666.81%10.86M
29.62%25.76M
-386.12%-19.54M
-62.10%15.91M
-96.92%-10.1M
-103.92%-693K
Net income continuous Operations
-26.69%18.89M
145.96%8.98M
163.72%41.96M
346.19%24.87M
1,666.81%10.86M
29.62%25.76M
-386.12%-19.54M
-62.10%15.91M
-96.92%-10.1M
-103.92%-693K
Minority interest income
Net income attributable to the parent company
-26.69%18.89M
145.96%8.98M
163.72%41.96M
346.19%24.87M
1,666.81%10.86M
29.62%25.76M
-386.12%-19.54M
-62.10%15.91M
-96.92%-10.1M
-103.92%-693K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-26.69%18.89M
145.96%8.98M
163.72%41.96M
346.19%24.87M
1,666.81%10.86M
29.62%25.76M
-386.12%-19.54M
-62.10%15.91M
-96.92%-10.1M
-103.92%-693K
Basic earnings per share
-26.79%0.41
144.19%0.19
160.00%0.91
345.45%0.54
1,250.00%0.23
27.27%0.56
-386.67%-0.43
-63.16%0.35
-83.33%-0.22
-105.00%-0.02
Diluted earnings per share
-23.53%0.39
144.19%0.19
161.76%0.89
336.36%0.52
1,250.00%0.23
27.50%0.51
-386.67%-0.43
-63.04%0.34
-83.33%-0.22
-105.13%-0.02
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 5.05%178.02M4.23%167.12M1.22%674.98M5.40%181.24M-2.11%163.93M0.03%169.47M1.49%160.34M23.14%666.82M8.02%171.96M31.12%167.47M
Operating revenue 5.05%178.02M4.23%167.12M1.22%674.98M5.40%181.24M-2.11%163.93M0.03%169.47M1.49%160.34M23.14%666.82M8.02%171.96M31.12%167.47M
Cost of revenue -8.18%44.26M-3.27%47.42M-7.34%184.67M-22.97%47.69M-21.56%39.75M-4.78%48.21M35.89%49.02M42.09%199.3M58.73%61.92M46.25%50.68M
Gross profit 10.31%133.76M7.53%119.7M4.87%490.31M21.37%133.55M6.33%124.18M2.08%121.26M-8.69%111.32M16.51%467.53M-8.44%110.04M25.48%116.79M
Operating expense 4.89%102.79M2.23%104.59M1.61%402.99M3.96%99.59M8.51%103.1M-7.21%98M2.11%102.31M47.74%396.6M27.18%95.8M54.74%95.01M
Selling and administrative expenses 5.05%68.13M1.67%72.03M5.86%269.44M2.86%65.8M10.87%67.95M-0.24%64.85M10.24%70.84M27.68%254.52M22.66%63.97M28.06%61.28M
-Selling and marketing expense 4.23%39.05M-5.16%39.44M5.55%153.04M-0.72%35.74M13.51%38.26M1.65%37.46M8.17%41.58M--145M--36M28.16%33.71M
-General and administrative expense 6.17%29.08M11.37%32.59M6.28%116.4M7.47%30.06M7.65%29.69M-2.70%27.39M13.34%29.26M--109.52M--27.97M27.93%27.58M
Research and development costs 8.04%20.34M6.41%18.24M-10.07%76.26M11.19%19.46M7.34%20.83M-28.38%18.82M-20.67%17.14M52.66%84.8M12.83%17.51M67.60%19.41M
Depreciation amortization depletion 0.00%14.32M0.00%14.32M0.00%57.29M0.00%14.32M0.00%14.32M0.00%14.32M0.00%14.32M322.70%57.29M87.14%14.32M628.11%14.32M
-Depreciation and amortization 0.00%14.32M0.00%14.32M0.00%57.29M0.00%14.32M0.00%14.32M0.00%14.32M0.00%14.32M322.70%57.29M87.14%14.32M628.11%14.32M
Operating profit 33.15%30.98M67.65%15.12M23.12%87.32M138.49%33.97M-3.22%21.08M76.55%23.26M-58.51%9.02M-46.61%70.93M-68.26%14.24M-31.23%21.78M
Net non-operating interest income expense 149.32%865K109.11%587K74.99%-8.86M100.45%37K91.90%-698K79.56%-1.75M35.37%-6.45M-14.84%-35.43M20.18%-8.26M-20.49%-8.62M
Non-operating interest income 124.96%4.75M24.22%3.9M151.96%11.44M22.98%3.43M124.15%2.77M737.70%2.11M1,059.41%3.14M406.92%4.54M3,381.25%2.79M597.18%1.23M
Non-operating interest expense -1.67%3.12M-69.54%2.64M-51.34%17.31M-71.83%2.7M-68.94%2.78M-60.12%3.17M-4.58%8.65M22.69%35.58M-0.50%9.6M34.29%8.95M
Total other finance cost 10.42%763K-27.32%681K-31.91%3M-52.56%685K-24.36%683K-20.94%691K-20.53%937K59.77%4.4M85.60%1.44M35.59%903K
Other net income (expense) -70.97%4.74M92.90%-2.06M24.47%-16.76M98.82%-283K65.92%-3.78M-6.13%16.34M-551.04%-29.04M51.31%-22.19M40.93%-24.05M-3,817.67%-11.09M
Special income (charges) -71.21%4.78M93.45%-1.9M-52.01%-16.57M96.69%-798K-586.30%-3.36M-8.00%16.61M-569.43%-29.03M74.59%-10.9M40.63%-24.14M-106.33%-489K
-Less：Restructuring and merger&acquisition 116.46%2.74M-84.28%1.9M-103.23%-352K-96.69%798K586.30%3.36M8.00%-16.61M179.16%12.11M-74.59%10.9M-40.63%24.14M106.33%489K
-Less:Other special charges ---7.52M------16.93M--0----------16.93M------------
Other non- operating income (expenses) 85.50%-39K-1,490.00%-159K98.35%-186K535.80%515K96.02%-422K58.42%-269K91.94%-10K-323.41%-11.29M222.73%81K-22,939.13%-10.6M
Income before tax -3.35%36.58M151.52%13.64M363.85%61.7M286.63%33.72M702.37%16.6M72.01%37.85M-462.96%-26.47M-76.42%13.3M-191.51%-18.07M-91.46%2.07M
Income tax 46.37%17.7M167.18%4.66M857.42%19.75M211.10%8.85M107.93%5.74M467.39%12.09M-1,588.84%-6.94M-118.07%-2.61M-645.88%-7.97M-57.97%2.76M
Net income -26.69%18.89M145.96%8.98M163.72%41.96M346.19%24.87M1,666.81%10.86M29.62%25.76M-386.12%-19.54M-62.10%15.91M-96.92%-10.1M-103.92%-693K
Net income continuous Operations -26.69%18.89M145.96%8.98M163.72%41.96M346.19%24.87M1,666.81%10.86M29.62%25.76M-386.12%-19.54M-62.10%15.91M-96.92%-10.1M-103.92%-693K
Minority interest income
Net income attributable to the parent company -26.69%18.89M145.96%8.98M163.72%41.96M346.19%24.87M1,666.81%10.86M29.62%25.76M-386.12%-19.54M-62.10%15.91M-96.92%-10.1M-103.92%-693K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -26.69%18.89M145.96%8.98M163.72%41.96M346.19%24.87M1,666.81%10.86M29.62%25.76M-386.12%-19.54M-62.10%15.91M-96.92%-10.1M-103.92%-693K
Basic earnings per share -26.79%0.41144.19%0.19160.00%0.91345.45%0.541,250.00%0.2327.27%0.56-386.67%-0.43-63.16%0.35-83.33%-0.22-105.00%-0.02
Diluted earnings per share -23.53%0.39144.19%0.19161.76%0.89336.36%0.521,250.00%0.2327.50%0.51-386.67%-0.43-63.04%0.34-83.33%-0.22-105.13%-0.02
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data